Peeter Padrik

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 111 citations · Full text

Metastatic Breast Cancer, Breast Oncology, Medicine +7

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2021 · 83 citations · Full text

Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results

Simon J. Harrison, Paul N. Mainwaring, Timothy Price et al. · Clinical Cancer Research · 2016 · 71 citations

Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification

Kristi Läll, Maarja Lepamets, Marili Palover et al. · BMC Cancer · 2019 · 49 citations · Full text

Identification of Bull Semen Microbiome by 16S Sequencing and Possible Relationships with Fertility

Aleksandar Cojkić, Adnan Niazi, Yongzhi Guo et al. · Microorganisms · 2021 · 47 citations · Full text